Showing 1221-1230 of 2217 results for "".
- Korean Skincare Brand Launches in US with Sensitive-Skin Formulationshttps://modernaesthetics.com/news/korean-skincare-brand-launches-in-us-with-sensitive-skin-formulations/2483054/South Korean skincare brand Hexkin has entered the US market, offering products formulated for sensitive skin using collagen-based and peptide-driven technologies, according to a press release. Rooted in traditional Korean sk
- Noninvasive Brain Stimulation for Mental Wellness Coming to Illinois Dermatology Clinichttps://modernaesthetics.com/news/noninvasive-brain-stimulation-mental-wellness-coming-illinois-dermatology-clinic/2482956/An Illinois dermatology clinic is now offering a noninvasive brain stimulation treatment for patients experiencing depression, anxiety, and related mental health concerns. Dundee Dermatology recently introduced EXOMIND, a transcranial magnetic stimulation (TMS) device that is FDA
- BOTOX Cosmetic Selects Entrepreneurs for 2025 Confidence Projecthttps://modernaesthetics.com/news/botox-cosmetic-selects-entrepreneurs-for-2025-confidence-project/2475812/Allergan Aesthetics, an AbbVie company, announced the 2025 class of participants in The Confidence Project: Empowering Women Entrepreneurs, a national program led by BOTOX Cosmetic (onabotulinumtoxinA). The initiative is designed to address the confidence gap among women in business and
- Global Botulinum Toxins Market Projected to Reach $15.7 Billion by 2030https://modernaesthetics.com/news/global-botulinum-toxins-market-projected-to-reach-157-billion-by-2030/2475785/The global market for botulinum toxin products is expected to grow from $8.9 billion in 2025 to $15.7 billion by 2030, according to new projections from MarketsandMarkets, representing a compound annual growth rate (CAGR) of 11.7%. This sustained growth is attributed to increased global de
- CollPlant Appoints Bowman Bagley to Lead North American Commercial Operationshttps://modernaesthetics.com/news/collplant-appoints-bowman-bagley-to-lead-north-american-commercial-operations/2475724/CollPlant Biotechnologies has appointed Bowman Bagley as Vice President, Commercial North America, a newly established role aimed at expanding the company’s commercial presence and operations in the region. Bagley will oversee sales, marketing, lo
- Study: CINDR of Masseter Muscle Optimal Injection Site for Botoxhttps://modernaesthetics.com/news/study-cindr-of-masseter-muscle-optimal-injection-site-for-botox/2475664/Research published in the Annals of Anatomy journal indicates the center of the intramuscular nerve dense region (CINDR) of the masseter muscle as the optimal botulinum neurotoxin A (BoNT-A) injection site. The researchers used 60 rabbits to assess BoNT-A injection efficacy at the CINDR.<
- Sinclair North America Introduces Inaugural Advisory Boardhttps://modernaesthetics.com/news/sinclair-north-america-introduces-inaugural-advisory-board/2475577/Sinclair North America announced its inaugural Advisory Board, consisting of 16 plastic surgeons, dermatologists, aesthetic practitioners, and aestheticians. The board will advance Sinclair North America’s mission of delivering a timeless and trending portfolio of clinically-validated prod
- Popular K-Beauty Brand Expands PDRN Collectionhttps://modernaesthetics.com/news/popular-k-beauty-brand-expands-pdrn-collection/2475554/Korean Beauty brand Abib is expanding its polydeoxyribonucleotide (PDRN) collection. According to a press release, the collection aims to elevate daily skincare routines—offering your patients a “sensorial, luxurious experience” without breaking t
- Epicutis Introduces Skin Barrier Support Mist with Microbiome Focushttps://modernaesthetics.com/news/epicutis-introduces-skin-barrier-support-mist-with-microbiome-focus/2475454/Epicutis has announced the release of Hydrobiome Mist, a skin care product formulated to support skin barrier function and microbiome balance. The mist is intended to hydrate, protect agai
- Study Highlights Role of Patient-Reported Outcomes in Botulinum Toxin Developmenthttps://modernaesthetics.com/news/study-highlights-role-of-patient-reported-outcomes-in-botulinum-toxin-development/2475414/A patient-centric clinical approach, driven by the evolution of patient-reported outcomes (PROs), has been central to the development of onabotulinumtoxinA for aesthetic indications, according to new research in the Journal of Cosmetic Dermatology. Researchers concluded there is i